BRANMOOR
THURSDAY · 14 MAY 2026

Penicillin G Benzathin

Injection · trading as Lentocilin

Current Active — Day 1114 FDA record updated

High impact — Only one manufacturer supplies this drug; any disruption leaves no immediate alternative source.

FDA shortage record

Substance
Penicillin G Benzathin
Brand name
Lentocilin
Manufacturers / suppliers
  • LABORATRIOS ATRAL, S.A.
  • Laboratorios Atral
2 known suppliers in current FDA data
Dosage form
Injection
Presentation
Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01)
Route(s)
INTRAMUSCULAR
Therapeutic category
Anti-Infective
Package NDC
84383-110-01
Initially posted
04/26/2023
Days on shortage list
1114
Current FDA status
Current
Shortage entries (current dataset)
1 record for Penicillin G Benzathin

Why this shortage matters

Anti-infective drugs — antibiotics, antivirals, and antifungals — treat bacterial, viral, and fungal infections. A shortage can delay care for serious hospital-acquired or opportunistic infections, where drug choice and timing directly affect patient outcomes.

FDA therapeutic class: Anti-Infective

Manufacturer contact

Per the FDA record, the manufacturer's contact for supply inquiries is Mark Cuban Cost Plus Drug Company: 682-428-8081.

If you're affected by this shortage

  • Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
  • Ask your pharmacy to check supply across multiple wholesalers and other branches.
  • Check current pharmacy pricing and availability via GoodRx (affiliate link).
  • Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.

Sources

Important

This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.